Aerie Pharmaceuticals Inc

ROYAL BANK OF CANADA

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

6,923

Value ($000)

105

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	105	0.0%	6,923	9/30/2022
2022 Q2	8/15/2022	75	0.0%	10,049	6/30/2022
2022 Q1	5/16/2022	87	0.0%	9,575	3/31/2022
2021 Q4	2/14/2022	106	0.0%	15,255	12/31/2021
2021 Q3	11/15/2021	34	0.0%	2,969	9/30/2021
2021 Q2	8/16/2021	20	0.0%	1,266	6/30/2021
2021 Q1	7/20/2021	61	0.0%	3,461	3/31/2021
2020 Q4	2/16/2021	33	0.0%	2,384	12/31/2020
2020 Q3	11/16/2020	27	0.0%	2,327	9/30/2020
2020 Q2	8/14/2020	36	0.0%	2,462	6/30/2020
2020 Q1	6/16/2020	43	0.0%	3,160	3/31/2020
2019 Q4	2/14/2020	198	0.0%	8,200	12/31/2019
2014 Q1	5/15/2014	905	0.0%	42,727	3/31/2014
2013 Q4	2/14/2014	5	0.0%	275	12/31/2013